1. Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid- and Calcineurin Inhibitor-Free Future?

   • Florence Herr
   • Melanie Brunel
   • Antoine Durrbach

   Leading Article 26 October 2016 Pages: 1589 - 1600

   

2. Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects

   • Pilar Brito-Zerón
   • Soledad Retamozo
   • Manuel Ramos-Casals

   Leading Article 14 November 2016 Pages: 1601 - 1623

   

3. Cytomegalovirus Vaccines: Current Status and Future Prospects

   • K. M. Anderholm
   • C. J. Bierle
   • M. R. Schleiss

   Review Article 24 November 2016 Pages: 1625 - 1645

   

4. Isavuconazole: A Review in Invasive Aspergillosis and Mucormycosis

   • Matt Shirley
   • Lesley J. Scott

   Adis Drug Evaluation 20 October 2016 Pages: 1647 - 1657

   

5. Ceftaroline Fosamil: A Review in Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia

   • Lesley J. Scott

   Adis Drug Evaluation 20 October 2016 Pages: 1659 - 1674

   

6. Vortioxetine: A Review in Cognitive Dysfunction in Depression

   • James E. Frampton

   Adis Drug Evaluation 02 November 2016 Pages: 1675 - 1682

7. Zoledronic Acid (Reclast^®, Aclasta^®): A Review in Osteoporosis

   • Sohita Dhillon

   Adis Drug Evaluation 18 November 2016 Pages: 1683 - 1697

8. Eteplirsen: First Global Approval

   • Yahiya Y. Syed

   AdisInsight Report 02 November 2016 Pages: 1699 - 1704